Company Information
Ask for more detail from the seller
Contact SupplierTrastuzumab is currently approved for breast cancer and metastatic gastric cancer. It is a humanized IgG1 kappa recombinant monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein (HER2).